Analysis of B-ultrasound and contrast-enhanced ultrasound characteristics of different hepatic neuroendocrine neoplasm

被引:7
作者
Kang, Xiao-Ning [1 ]
Zhang, Xiao-Yu [2 ]
Bai, Jie [2 ]
Wang, Zun-Yi [2 ]
Yin, Wen-Jie [3 ]
Li, Li [1 ]
机构
[1] Cangzhou Cent Hosp, Dept Ultrasound 2, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China
[2] Cangzhou Cent Hosp, Dept Oncol 3, Cangzhou 061001, Hebei, Peoples R China
[3] Cangzhou Cent Hosp, Dept Gastroenterol, Cangzhou 061001, Hebei, Peoples R China
关键词
Hepatic neuroendocrine neoplasm; Hepatic neuroendocrine tumor; Hepatic neuroendocrine carcinoma; B-ultrasound; Contrast-enhanced ultrasound; TRANSARTERIAL CHEMOEMBOLIZATION TACE; HEPATOCELLULAR-CARCINOMA HCC; LIVER METASTASES; SURGICAL-MANAGEMENT; CLINICAL ANALYSIS; TUMOR; DIAGNOSIS; TRANSPLANTATION; FEATURES; G3;
D O I
10.4251/wjgo.v11.i5.436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Hepatic neuroendocrine neoplasm (hNEN) is a highly heterogeneous tumor. The exact identification of the source and malignant degree of hNEN is important. However, there is a lack of information regarding diagnosis of hNEN with imaging. In addition, no studies have compared the imaging between hNEN and hepatocellular carcinoma (HCC) and among different sources and malignant degrees of hNEN. AIM To compare the ultrasound characteristics between hNEN and HCC and among different sources and malignant degrees of hNEN. METHODS A total of 55 patients with hNEN were recruited and defined as the hNEN group. Among them, 35 cases of hNET were defined as the hNET group. Twenty cases of hepatic neuroendocrine carcinoma (hNEC) were defined as the hNEC group. Among the 55 lesions, 29 were transferred from the pancreas, 20 were from the gastrointestinal tract, and six were from other sites. In total, 55 patients with HCC were recruited and defined as the HCC group. The characteristic differences of Bmode ultrasound and contrast-enhanced ultrasound (CEUS) between hNEN and HCC and among different sources and malignant degrees of hNEN were compared. RESULTS In the hNEN group, the proportions of multiple liver lesions, unclear borders, and high echo lesions were higher than those in the HCC group. The proportions of non-uniform echo and peripheral acoustic halo were lower than those in the HCC group (P < 0.05). The washout to iso-enhancement time an d washout to hypo-enhancement time were lower than those in the HCC group (P < 0.05). The characteristics of B-ultrasound and CEUS among different sources of hNEN were similar, and the differences were not statistically significant (P > 0.05). B-mode ultrasound characteristics of hNET and hNEC were similar. The proportions of low enhancement at portal venous phase, non-uniform enhancement forms, and combined tumor vasculature in the hNEC group were larger than those in the hNEN group (P < 0.05). CONCLUSION Compared with HCC, hNEN showed multiple intrahepatic lesions, uniform high echo, uniform high enhancement at arterial phase, and rapid washout. Low enhancement at portal venous phase, overall non-uniform enhancement form, and the proportion of combined tumor vasculature in hNEC were larger than those in hNET.
引用
收藏
页码:436 / 448
页数:13
相关论文
共 48 条
[1]  
Beard RE, 2017, INT J SURG CASE REP, V37, P26, DOI 10.1016/j.ijscr.2017.05.039
[2]  
Bosman FT, 2010, WHO Classification of tumors of the digestive system
[3]   Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies? [J].
Cavalcoli, Federica ;
Rausa, Emanuele ;
Conte, Dario ;
Nicolini, Antonio Federico ;
Massironi, Sara .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (15) :2640-2650
[4]   Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival [J].
Chen, James X. ;
Rose, Steven ;
White, Sarah B. ;
El-Haddad, Ghassan ;
Fidelman, Nicholas ;
Yarmohammadi, Hooman ;
Hwang, Winifred ;
Sze, Daniel Y. ;
Kothary, Nishita ;
Stashek, Kristen ;
Wileyto, E. Paul ;
Salem, Riad ;
Metz, David C. ;
Soulen, Michael C. .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (01) :69-80
[5]  
Chung Haniee, 2014, Adv Surg, V48, P235
[6]   Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement [J].
Coriat, Romain ;
Walter, Thomas ;
Terris, Benoit ;
Couvelard, Anne ;
Ruszniewski, Philippe .
ONCOLOGIST, 2016, 21 (10) :1191-1199
[7]   GEP-NETS UPDATE Interventional radiology: role in the treatment of liver metastases from GEP-NETs [J].
de Baere, Thierry ;
Deschamps, Frederic ;
Tselikas, Lambros ;
Ducreux, Michel ;
Planchard, David ;
Pearson, Ernesto ;
Berdelou, Amandine ;
Leboulleux, Sophie ;
Elias, Dominique ;
Baudin, Eric .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (04) :R151-R166
[8]   Multidisciplinary approach for the treatment of neuroendocrine tumors [J].
de Herder, Wouter W. ;
Mazzaferro, Vincenzo ;
Tavecchio, Luca ;
Wiedenmann, Bertram .
TUMORI JOURNAL, 2010, 96 (05) :833-836
[9]   Comparison of Transarterial Liver-Directed Therapies for Low-Grade Metastatic Neuroendocrine Tumors in a Single Institution [J].
Engelman, Eric S. ;
Leon-Ferre, Roberto ;
Naraev, Boris G. ;
Sharma, Nancy ;
Sun, Shiliang ;
O'Dorisio, Thomas M. ;
Howe, James ;
Button, Anna ;
Zamba, Gideon ;
Halfdanarson, Thorvardur R. .
PANCREAS, 2014, 43 (02) :219-225
[10]   Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors [J].
Fiore, Francesco ;
Del Prete, Michela ;
Franco, Renato ;
Marotta, Vincenzo ;
Ramundo, Valeria ;
Marciello, Francesca ;
Di Sarno, Antonella ;
Carratu, Anna Chiara ;
di Roseto, Chiara de Luca ;
Colao, Annamaria ;
Faggiano, Antongiulio .
ENDOCRINE, 2014, 47 (01) :177-182